The FDA is proposing that it give medical device makers about half a year’s notice before terminating emergency use authorizations post-pandemic.
That was one of the major takeaways from the draft guidance that the FDA released today. It considers ways to transition medical device regulation once COVID-19 moves from a pandemic to an endemic phase. There are presently hundreds of medical devices sold in the U.S. under EUAs issued during the pandemic.
